Treatment of ADHD in Tourette’s Syndrome

J Gordon Millichap

doi:10.15844/pedneurbriefs-9-1-8

Treatment of ADHD in Tourette’s Syndrome

Pediatric Neurology Briefs

Volume 9 (1995): Issue 1

By: J Gordon Millichap

Open Access

|Jan 1995

Abstract

A double-blind, placebo-controlled study of clonidine (.05 mg 4xd) and desipramine (25 mg 4xd) treatment of attention-deficit hyperactivity disorder (ADHD) behaviors in 34 children with TS + ADHD is reported from the Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.

References

Singer HS Brown J Quaskey S Rosenberg LA Mellits ED Denckla MB The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine Pediatrics 1995 Jan 95 1 74 81 7770313
Search in Google Scholar Back to article
Kurlan R Eapen V Stern J McDermott MP Robertson MM Bilineal transmission in Tourette’s syndrome families Neurology 1994 Dec 44 12 2336 42 7991122 10.1212/WNL.44.12.2336
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-9-1-8 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 6 - 6

Published on: Jan 1, 1995

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Attention-Deficit Hyperactivity Disorder,

Child Behavior Checklist,

Global Linear Analogue

© 1995 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 9 (1995): Issue 1